GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
GLOW Blend 50mg
Glow

GLOW Blend 50mg

GHK-Cu / SNAP-8 / DSIP

CAS: 49557-75-7 / 868844-74-0 / 62568-57-4

$80.99$89.9910% OFFIn Stock

GLOW Blend 50mg combines GHK-Cu (collagen/antioxidant), SNAP-8 (SNARE inhibitor for expression lines), and DSIP (sleep/recovery) in a single vial. Targets the three key dimensions of skin aging: structural matrix, neuromuscular activity, and sleep-dependent repair. 98.8% HPLC purity.

Specifications

Vial Size50mg blend
FormLyophilized Powder
Purity98.8% HPLC
CAS49557-75-7 / 868844-74-0 / 62568-57-4
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Triple-mechanism skin protocol: GHK-Cu drives fibroblast collagen/elastin synthesis via copper-dependent gene activation. SNAP-8 competitively inhibits SNAP-25 to reduce muscular contraction intensity. DSIP supports the slow-wave sleep architecture during which skin repair peaks.

Research FAQ

Why combine DSIP with GHK-Cu and SNAP-8?

Peak skin cell regeneration occurs during slow-wave sleep. DSIP supports this sleep phase, GHK-Cu drives the collagen synthesis that peaks during sleep-dependent repair, and SNAP-8 reduces daytime expression line formation — covering all three skin aging axes.

Related Compounds